AI assistant
GLAUKOS Corp — Director's Dealing 2022
Dec 19, 2022
31074_dirs_2022-12-19_bc3f9bd7-a806-475c-a335-79ef3114f570.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2022-12-15
Reporting Person: Burns Thomas William (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-15 | Common Stock | A | 10420 | — | Acquired | 684705 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-15 | Stock Option (Right to Buy) | $55.18 | A | 21039 | Acquired | 2032-03-24 | Common Stock (21039) | Direct |
Footnotes
F1: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 70% of the number of shares of common stock reported herein will vest and be delivered in January 2023, and the remaining 30% will vest and be delivered in March 2023.
F2: Includes 91,279 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F4: 70% of the portion of the option reported herein will vest and become exercisable in January 2023, and the remaining 30% will vest and become exercisable in March 2023.